Yi Wei
Impact in
- Otorhinolaryngology top 10%
- Head and Neck Cancer Studies
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 9
- Viral-associated cancers and disorders 4
- Cancer-related Molecular Pathways 3
- Co-authors
- Jie Li (1 shared paper)Zeguang Zheng (1 shared paper)Lianghui Liu (1 shared paper)Xinyun Yang (1 shared paper)Wei Li (1 shared paper)Huan Liu (1 shared paper)Zhijian Cao (1 shared paper)Yu Sun (1 shared paper)
- Journals
- Medicine (4 papers)Chinese Journal of Cancer (2 papers)Frontiers in Oncology (2 papers)International Journal of Oncology (1 paper)Annals of Translational Medicine (1 paper)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Yi Wei
36 papers receiving 626 citations
Peers
Comparison fields: 5 of 94
- Otorhinolaryngology 39
- Hepatology 47
- Cancer Research 83
- Family Practice 8
- Oncology 97
Countries citing papers authored by Yi Wei
This map shows the geographic impact of Yi Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Wei more than expected).
Fields of papers citing papers by Yi Wei
This network shows the impact of papers produced by Yi Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Wei. The network helps show where Yi Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yi Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 93 | |
| 2 | 2016 | 86 | |
| 3 | 2014 | 54 | |
| 4 | 2015 | 38 | |
| 5 | 2023 | 34 | |
| 6 | 2006 | 30 | |
| 7 | 2015 | 25 | |
| 8 | 2004 | 25 | |
| 9 | 2021 | 24 | |
| 10 | 2009 | 19 | |
| 11 | 2018 | 18 | |
| 12 | 2008 | 17 | |
| 13 | Puerarin inhibits proliferation and induces apoptosis in human glioblastoma cell lines. | 2015 | 17 |
| 14 | 2020 | 16 | |
| 15 | The expression status of ZIC2 as a prognostic marker for nasopharyngeal carcinoma. | 2018 | 16 |
| 16 | 2015 | 15 | |
| 17 | 2021 | 15 | |
| 18 | 2020 | 14 | |
| 19 | 2007 | 12 | |
| 20 | 2014 | 10 |
About Yi Wei
Yi Wei is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Otorhinolaryngology and Pulmonary and Respiratory Medicine, having authored 39 papers that have together received 635 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (4 papers), Viral-associated cancers and disorders (4 papers), interferon and immune responses (3 papers), Cancer-related Molecular Pathways (3 papers), Glioma Diagnosis and Treatment (3 papers), Nitric Oxide and Endothelin Effects (2 papers), Renal cell carcinoma treatment (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Otorhinolaryngology (39 citations), Hepatology (47 citations), Cancer Research (83 citations), Family Practice (8 citations) and Oncology (97 citations). Yi Wei has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Jie Li, Zeguang Zheng, Lianghui Liu, Xinyun Yang, Wei Li, Huan Liu, Zhijian Cao, Yu Sun, Zan Huang and Ke Peng. Their work appears in journals such as Medicine, Chinese Journal of Cancer, Frontiers in Oncology, International Journal of Oncology and Annals of Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.